Akèy › Metiyè › Biochemists and Biophysicists › Gaithersburg, MD
Biochemists and Biophysicists nan Gaithersburg, MD: Salè H-1B
78 aplikasyon kondisyon travay pou okipasyon sa a ak yon sit travay nan Gaithersburg, MD. Salè baz medyàn ofri $119,472; mwatye mitan $103,901–$126,428.
Pa nivo salè
| Nivo revni | Salè medyan |
|---|---|
| Nivo I (antre) | $117,521 |
| Nivo II (kalifye) | $117,986 |
| Nivo III (eksperyans) | $123,757 |
| Nivo IV (plen kompetans) | $184,707 |
Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.
Anplwayè yo
| Anplwayè | LCA | Salè medyan |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 31 | $121,200 |
| MedImmune LLC | 25 | $121,514 |
| Institute for In Vitro Sciences, Inc. | 5 | $86,424 |
| Axle Informatics LLC | 4 | $102,500 |
| Meso Scale Diagnostics, LLC | 3 | $113,949 |
| Hepanova Inc | 2 | $72,000 |
| Georgetown University | 1 | $72,000 |
| Theiss Research | 1 | $75,800 |
| Novavax, Inc. | 1 | $115,000 |
| GAP Solutions Inc. | 1 | $152,000 |
| Kelly Services, Inc. | 1 | $119,413 |
| Janssen Research & Development, LLC | 1 | $158,414 |
| Eurofins Lancaster Laboratories Professional Scientific Services, LLC | 1 | $95,680 |
| Emergent Product Development Gaithersburg Inc. | 1 | $155,563 |
Tit travay
- Senior Scientist24
- Scientist12
- Scientist, Cancer Immunology, Oncology Research3
- Biochemist2
- Senior Scientist, Translational Medicine2
- Toxicologist I2
- Specialist, Clinical Biologics2
- Director, Cell Culture and Fermentation Sciences2
- Scientist, Cancer Biology (Antibody Drug Conjugates)2
- Senior Scientist - Early Stage Formulation Sciences2
- Associate Principal Scientist2
- Senior Scientist, Proteomics2
- Postdoctoral Fellow1
- Scientist, Bioscience - Bispecific Antibody Technologies1
- Project Scientist1
Pwonse H-1B nan Gaithersburg, MD →
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).